摘要
表观遗传学是一个生物科学领域,专注于研究基因功能的可逆、可遗传变化,而不是由于基因组序列的修改。这些变化是几种分子机制之间复杂的串扰的结果,而这些机制又由遗传和环境因素精心策划。表观遗传图谱捕捉了个体独特的监管环境和环境刺激的暴露情况。因此,它构成了个性化医疗的宝贵信息库,旨在根据每个人的独特特征定制医疗干预措施。如今,由于大规模的高通量技术,可以在全基因组水平上研究表观基因组标记的复杂环境。这种新的实验方法开辟了新的有趣的知识视角。然而,分析这些复杂的组学数据需要面对重要的分析问题。人工智能,尤其是机器学习(ML),正在成为破译表观基因组数据的强大资源。在这篇综述中,我们将首先描述表观基因组学中最常用的 ML 方法。然后,我们将概括最近 ML 在表观基因组分析中的一些应用。最后,我们将提供一些示例,说明表观遗传数据的 ML 方法如何用于个性化医疗。
关键词: 人工智能、个性化医疗、机器学习、数据挖掘、表观基因组学、多组学。
Current Medicinal Chemistry
Title:Artificial Intelligence for Epigenetics: Towards Personalized Medicine
Volume: 28 Issue: 32
关键词: 人工智能、个性化医疗、机器学习、数据挖掘、表观基因组学、多组学。
摘要:
Epigenetics is a field of biological sciences focused on the study of reversible, heritable changes in gene function, not due to modifications of the genomic sequence. These changes are the result of a complex cross-talk between several molecular mechanisms that is in turn orchestrated by genetic and environmental factors. The epigenetic profile captures the unique regulatory landscape and the exposure to environmental stimuli of an individual. It thus constitutes a valuable reservoir of information for personalized medicine, which is aimed at customizing health-care interventions based on the unique characteristics of each individual.
Nowadays, the complex milieu of epigenomic marks can be studied at the genome-wide level thanks to massive, high-throughput technologies. This new experimental approach is opening up new and interesting knowledge perspectives. However, the analysis of these complex omic data requires to face important analytic issues.
Artificial Intelligence, and in particular Machine Learning, are emerging as powerful resources to decipher epigenomic data. In this review, we will first describe the most used ML approaches in epigenomics. We then will recapitulate some of the recent applications of ML to epigenomic analysis. Finally, we will provide some examples of how the ML approach to epigenetic data can be useful for personalized medicine.
Export Options
About this article
Cite this article as:
Artificial Intelligence for Epigenetics: Towards Personalized Medicine, Current Medicinal Chemistry 2021; 28 (32) . https://dx.doi.org/10.2174/0929867327666201117142006
DOI https://dx.doi.org/10.2174/0929867327666201117142006 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease
Current Cardiology Reviews Myocardial Energetics in Left Ventricular Hypertrophy
Current Cardiology Reviews Clinical Applications and Biosafety of Human Adult Mesenchymal Stem Cells
Current Pharmaceutical Design Pharmacological Modulations of the Renin-Angiotensin-Aldosterone System in Human Congestive Heart Failure: Effects on Peripheral Vascular Endothelial Function
Current Vascular Pharmacology Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases
Cardiovascular & Hematological Disorders-Drug Targets Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews The Anti-Inflammatory Potential of ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Evidence from Basic and Clinical Research
Current Drug Targets Endogenous Cardiotonics: Search and Problems
Cardiovascular & Hematological Disorders-Drug Targets Gender Differences in the Effects of Angiotensin Receptor Blockers on Cardiovascular Disease
Current Pharmaceutical Design Cardioprotective Potential of Iron Chelators and Prochelators
Current Medicinal Chemistry Synthesis and Biological Activity of the Pyridine-hexacyclic-steroid Derivative on a Heart Failure Model
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Clinical Features of Scleroderma-Like Disorders: A Challenge for the Rheumatologist
Current Rheumatology Reviews Inhibition of Sphingomyelin Hydrolysis: Targeting the Lipid Mediator Ceramide as a Key Regulator of Cellular Fate
Current Medicinal Chemistry Nicotine Addiction and Coronary Artery Disease: Impact of Cessation Interventions
Current Pharmaceutical Design Novel Agents Targeting Nitric Oxide
Current Vascular Pharmacology The Role of Transesophageal Echocardiography in the Intraoperative Period
Current Cardiology Reviews Polyphenols: Potential Future Arsenals in the Treatment of Diabetes
Current Pharmaceutical Design The ErbB Receptors and their Ligands in Cancer: An Overview
Current Drug Targets Quantitative Analysis in Cardiovascular Imaging: Current Status
Current Medical Imaging Endothelin Receptor Antagonists: Another Potential Alternative for Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders